42
TITLE: University social responsibility as a driving force of change: students' perceptions beyond the ivory tower
AUTHORS: Marcia Coelho; Isabel Menezes;
PUBLISHED: 2020, SOURCE: ON THE HORIZON, VOLUME: 28, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef
43
TITLE: Active and prospective latent tuberculosis are associated with different metabolomic profiles: clinical potential for the identification of rapid and non-invasive biomarkers
AUTHORS: Albors Vaquer, A; Rizvi, A; Matzapetakis, M; Lamosa, P; Coelho, AV; Patel, AB; Mande, SC; Gaddam, S; Pineda Lucena, A; Banerjee, S; Puchades Carrasco, L;
PUBLISHED: 2020, SOURCE: EMERGING MICROBES & INFECTIONS, VOLUME: 9, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 22
IN MY: ORCID
44
TITLE: Reprogramming of Lipid Metabolism as a New Driving Force Behind Tauroursodeoxycholic Acid-Induced Neural Stem Cell Proliferation
AUTHORS: Fernandes, MB; Costa, M; Ribeiro, MF; Siquenique, S; Santos, SS; Martins, J; Coelho, AV; Silva, MFB; Rodrigues, CMP; Sola, S;
PUBLISHED: 2020, SOURCE: FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, VOLUME: 8
INDEXED IN: Scopus WOS CrossRef: 7
IN MY: ORCID
45
TITLE: Grapevine-Downy Mildew Rendezvous: Proteome Analysis of the First Hours of an Incompatible Interaction
AUTHORS: Santos, RB; Nascimento, R; Coelho, AV; Figueiredo, A;
PUBLISHED: 2020, SOURCE: PLANTS-BASEL, VOLUME: 9, ISSUE: 11
INDEXED IN: Scopus WOS CrossRef: 11
IN MY: ORCID
46
TITLE: Protein Biomarkers May Differentiate Responders and Non-Responders to Adalimumab, a Tumour Necrosis Factor Inhibitor, in Ankylosing Spondylitis Patients - The Bioefficacy SpA Study
AUTHORS: Ana Fernandes; Atlas Mashayekhi Sardoo; Miguel Bernardes; Patricia Pinto; Helena Santos; Joao Lagoas Gomes; Jose Tavares Costa; Jose A P da Silva; Joao Madruga Dias; Alexandra Bernardo; Jean Charles Gaillard; Lucia Domingues; Sara Maia; Jean Armengaud; Jaime C Branco; Ana Varela Coelho; Fernando Pimentel Santos;
PUBLISHED: 2020, SOURCE: ARTHRITIS & RHEUMATOLOGY, VOLUME: 72
INDEXED IN: WOS
IN MY: ORCID
Page 5 of 20. Total results: 199.